The International Consortium on Meningiomas (ICOM) is hosting a scientific day on Tuesday, May 21 as part of CNSF. Led by Dr. Gelareh Zadeh, this consortium was formed to increase awareness for this understudied disease and conduct cutting-edge meningioma research through international and multidisciplinary collaboration. This meeting’s program will feature updates on ongoing collaborative research as well as a practical overview of modern meningioma management, with themes including surgical management, biomarkers, clinical trials updates and more. We will also host a molecular tumour board where complex cases are reviewed by an expert multidisciplinary panel with opportunity for audience involvement. These sessions will be highly relevant to anyone involved in meningioma research or clinical care and all are welcome to attend.
Learn more on ICOM https://www.meningiomaconsortium.com
Scientific Committee
Register for ICOM Course: CNSF 2024 Congress - Choose Registration (eventscloud.com)
To submit an abstract for ICOM, please complete form below.
ICOM Abstract Submission
ICOM Agenda
Moderators: Michael Cusimano, Justin Wang
8:00 - 8:05 Overview of ICOM: Meningioma Consortium and 100th Anniversary of Neurosurgery
Gelareh Zadeh
8:05 - 8:20 Tumour microenvironment of meningioma
Christel Herold-Mende
8:20 - 8:35 Mutation landscape of meningioma grade progression
Kate Drummond
8:35 - 8:50 Epigenomic drivers of meningioma
Mark Youngblood
8:50 - 9:05 Metabolic landscape of aggressive meningioma
Alex Landry
9:05 - 9:20 Discussion/Break
9:20 - 9:35 Predictive Signatures for Meningiomas
Akash Patel
9:35 - 9:50 Role of radiotherapy for meningioma
Justin Wang
9:50 - 10:05 Biomarkers of radiation response
David Raleigh
10:05 - 10:20 Role of liquid biopsy
Houtan Noushmehr
10:20 - 10:35 Update on EANO guidelines for molecular testing, biomarker consortium
Susan Short
10:35 - 10:50 Break
10:50 - 11:00 Health-related quality of life in meningioma
Tobias Walbert
11:00 - 11:15 Development and validation of a quality of life questionnaire for meningioma
Michael Cusimano
11:15 - 11:30 Radiation induced meningioma
Farshad Nassiri
11:30 - 11:45 International Tuberculum Sellae Meningioma Study
Michael McDermott
11:45 - 12:00 Role of preoperative embolization
Vitor Pereira
12:00 - 12:15 Endoscopic anatomy from an ENT perspective
Ian Witterick
12:15 - 1:00 LUNCH
Moderators: Farshad Nassiri, Susan Short
1:00 - 2:00 Molecular Tumour Board
Speaker: Andrew Gao, Derek Tsang, Michel Cusimano, Jorge-Christian Tonn, Farshad Nassiri
2:00 - 2:15 Clinical Trials and Innovations in Meningioma Treatment
Patrick Wen
2:15 - 2:30 DODATATE and Theranostics of Meningioma: European Update
Jorge-Christian Tonn
2:30 - 2:45 Clinical Trial Design of Theranostics of Meningioma - North American Update
Erik Sulman
2:45 - 3:00 Alliance Trials and Opportunities: The role of umbrella trials in meningioma
Eva Galenis
3:00 - 3:15 ROAM Trial
Michael Jenkinson
3:15 - 3:30 Sex and racial disparities in meningioma
Quinn Ostrom
3:30 - 3:45 Updates on Molecular Pathology of Meningioma/WHO grading
Stephen Yip
3:45 - 4:00 Outcomes in grade 3 meniningioma
Alex Rebchuck
4:00 - 4:10 cIMPACT update
Felix Sahm
4:10 - 4:15 Discussion/ Closing Remarks
Speaker: Gelareh Zadeh